CK19 antibody and other epithelial markers: the pattern is the specificity control

Choosing and reading these markers

1. Know that keratin subtypes are informative and pan-keratin is not. A specific keratin marks a subset of epithelia and is used to distinguish lineages and ducts; a pan-keratin cocktail confirms epithelial identity and no more. Choose from the question, and state which reagent produced a result.
2. Recognise that E-cadherin and CDH1 are one protein. They are the protein name and the gene name for the same target, and catalogue entries use both. Reagents against different domains behave differently after fixation, so compare on the epitope rather than on the naming.
3. Read a tight junction protein as a continuous line. A junctional protein should appear as a continuous line at cell borders in an intact monolayer, and breaks in that line are the informative result in barrier experiments. Cytoplasmic staining of a junction protein means either disassembly or a failed stain, and the control tells you which.
4. Use the pattern as the specificity control. Membrane and junctional proteins have unmistakable patterns. A stain that is the right intensity in the wrong pattern is a warning that costs nothing to notice and is the fastest check available on these targets.
5. Match fixation to the junction. Junctional epitopes are sensitive to fixation and to permeabilisation, and methanol and aldehyde protocols preserve them differently. Test both on a confluent monolayer known to have intact junctions before interpreting anything.

Barrier experiments need more than a stain

Junction morphology and barrier function are different measurements and can disagree. A transepithelial resistance reading or a tracer flux assay measures the barrier; the stain shows where the protein is.

Report both where the claim is about barrier integrity. A study resting on junctional staining alone is describing a picture rather than measuring a function.

Change of state readouts

Loss of an epithelial junction marker with gain of a mesenchymal filament marker is the classic transition readout, and both halves are needed. A single marker moving is not a transition, and neither marker alone is diagnostic.

Quantify per cell rather than per field, because these transitions are usually partial and heterogeneous, and a field average hides exactly the heterogeneity that is the biology.

An sftpc antibody and the alveolar cell it marks

SFTPC marks alveolar type two cells and is processed from a precursor to a small hydrophobic peptide, so an sftpc antibody has to say which form it detects and the precursor is what most reagents see. In tissue the stain is granular and cytoplasmic, and the lung's own architecture is the control. It is a lineage marker in differentiation protocols as well as in pathology.

An atoh1 antibody and an intestinal lineage switch

ATOH1 decides the secretory lineage in the intestine, so an atoh1 antibody marks a small population and is read as nuclear positivity per crypt rather than as an intensity. It is a transcription factor at low abundance, which makes a nuclear extract and a positive tissue the two things that make a band interpretable. Family members share the basic domain.

A gata1 antibody and the erythroid factor

GATA1 is the erythroid and megakaryocytic lineage factor, so a gata1 antibody identifies those cells and is read against the family relative expressed in the same tissue, which is the cross reactivity to check. A short isoform arising from an alternative start is disease relevant, so the epitope position decides whether both are seen and the expected masses belong in the method.

A trypsin antibody and the enzyme in two contexts

A trypsin antibody detects the pancreatic protease as a tissue marker and as the enzyme used to digest samples, and in the second use the interest is contamination of a preparation rather than biology. The enzyme exists as a proenzyme and active forms, so the epitope decides which is seen. Autodigestion in a stored sample is why the band pattern changes with handling.

A cortactin antibody and where the protein sits

A cortactin antibody reports an actin binding protein found at junctions and at the leading edge, so its pattern is a thin rim and a set of puncta rather than a filled cytoplasm. Phosphorylation shifts where it is, which is why a phospho specific clone beside the total one is what an invasion experiment needs.

Common questions

Is an E-cadherin antibody different from a CDH1 antibody?

No, they are the protein and gene names for the same molecule, and suppliers list both. What differs between products is the epitope domain, which changes how they behave after fixation and whether they work on intact cells.

Why is my junction protein stain cytoplasmic?

Either the junctions have genuinely disassembled, which is often the result you are looking for, or the fixation and permeabilisation are wrong. A confluent untreated monolayer stained alongside distinguishes the two immediately.

Should I use a specific keratin or a pan-keratin cocktail?

A specific keratin when the question is which epithelial lineage or which duct compartment. A pan-keratin cocktail when the question is only whether the cells are epithelial at all.

What is the quickest specificity check on these markers?

The pattern. A junction protein should draw a line at cell borders and a keratin should fill a cytoplasm. Right intensity in the wrong pattern is a failed stain whatever the datasheet says.

Browse by service class

• Compare Gene synthesis on advertised prices